A carregar...
Targeting the adaptive molecular landscape of castration-resistant prostate cancer
Castration and androgen receptor (AR) pathway inhibitors induce profound and sustained responses in advanced prostate cancer. However, the inevitable recurrence is associated with reactivation of the AR and progression to a more aggressive phenotype termed castration-resistant prostate cancer (CRPC)...
Na minha lista:
| Publicado no: | EMBO Mol Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4520654/ https://ncbi.nlm.nih.gov/pubmed/25896606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201303701 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|